Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-002981

CHIEF EXECUTIVE OFFICER sold 9,102 shares at $48.22 ($438,921)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peetz Christopher CHIEF EXECUTIVE OFFICER 2025-02-03 Sale −9,102 $48.22 $438,921 115,920 D
Open-market sales · 9,102 sh · avg $48.22 · $438,921
Loading xslF345X05/form4-02042025_050204.xml…